P2Y12, a New Platelet ADP Receptor, Target of Clopidogrel

This publication has 20 references indexed in Scilit:

• ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999
  Journal of Biological Chemistry, 2001
• Identification of the platelet ADP receptor targeted by antithrombotic drugs
  Nature, 2001
• Identification and Biological Activity of the Active Metabolite of Clopidogrel
  Thrombosis and Haemostasis, 2000
• Role of P2Y1 purinoceptor in ADP‐induced platelet activation
  Published by Wiley ,1998
• Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel.
  British Journal of Haematology, 1997
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Rapid isolation of highly productive recombinant Chinese hamster ovary cell lines
  Gene, 1994
• Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent
  Cardiovascular Drug Reviews, 1993
• Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity.
  Proceedings of the National Academy of Sciences, 1980